Product NDC: | 0046-1100 |
Proprietary Name: | Premarin |
Non Proprietary Name: | ESTROGENS, CONJUGATED |
Active Ingredient(s): | .3 mg/1 & nbsp; ESTROGENS, CONJUGATED |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0046-1100 |
Labeler Name: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA004782 |
Marketing Category: | NDA |
Start Marketing Date: | 20060101 |
Package NDC: | 0046-1100-81 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0046-1100-81) |
NDC Code | 0046-1100-81 |
Proprietary Name | Premarin |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0046-1100-81) |
Product NDC | 0046-1100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ESTROGENS, CONJUGATED |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20060101 |
Marketing Category Name | NDA |
Labeler Name | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
Substance Name | ESTROGENS, CONJUGATED |
Strength Number | .3 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Estrogen [EPC],Estrogen Receptor Agonists [MoA],Estrogens, Conjugated (USP) [Chemical/Ingredient] |